New Key Statistics Module, Z-Score and F-Score
NAS:ALBO Key Ratios
| Market Cap $ M | 915.89 |
| Enterprise Value $ M | 745.07 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 9.13 |
| Price/Sales | 14.93 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 57.00 |
| EPS (TTM) $ | -6.72 |
| Beneish M-Score | 1.57 |
| 10-y EBITDA Growth Rate % | 29.60 |
| 5-y EBITDA Growth Rate % | 18.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -6.03 |
| EV-to-EBITDA | -6.05 |
| PEG | -- |
| Shares Outstanding M | 20.74 |
| Net Margin (%) | -228.51 |
| Operating Margin % | -214.17 |
| Pre-tax Margin (%) | -235.11 |
| Quick Ratio | 6.23 |
| Current Ratio | 6.32 |
| ROA % (ttm) | -46.51 |
| ROE % (ttm) | -91.17 |
| ROIC % (ttm) | -257.70 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.31 |
ALBO Number of Guru Trades
ALBO Volume of Guru Trades
Gurus Latest Trades with NAS:ALBO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ALBO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Albireo Pharma Inc Insider Transactions
No Available Data
News about NAS:ALBO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers